RESUMO
CONTEXT: Vitreoretinal large B- cell lymphoma (VR- LBCL) is a type of non- Hodgkin lymphoma confined to the eye and central nervous system (CNS). The clinical manifestations of intraocular lymphoma can precede, occur simultaneously with, or follow disease at CNS sites. It differs from other forms of extra-nodal lymphoma; in that it does not involve systemic sites other than CNS. OBJECTIVES: To analyse the clinical and pathological features, and treatment outcomes of a cohort of patients diagnosed with vitreoretinal lymphoma (VRL) in Royal Victoria Eye and Ear Hospital, Ireland between 2010 and 2024. METHOD: Retrospective review of medical records and pathology specimens of patients with ocular involvement in VR- LBCL over 14-year period and a review of the literature. RESULTS: Eight patients were included. All of them underwent pars plana vitrectomy and were confirmed to have VR- LBCL. The median age at diagnosis was 71 years. Three were men and five were women. Six had bilateral disease and two unilateral. Four of four patients had MYD88 L265P mutation present. Four patients showed a high interleukin-10 (IL-10) to interleukins-6 (IL-6) ratio in keeping with the diagnosis of VRL. Three patients had primary CNS lymphoma with subsequent eye involvement, despite systemic chemotherapy treatment. Of the five patients who presented with ocular lymphoma, two patients had CNS involvement after primary vitreoretinal lymphoma was diagnosed. Of those, one was initially treated with local intravitreal chemotherapy. Three patients had no CNS recurrence. At the time of this study, seven patients of eight are alive, four are disease free and two are on a first- line local chemotherapy treatment. One underwent treatment for CNS relapse. One patient died of the disease before commencing targeted therapy. CONCLUSION: This case series demonstrated excellent treatment outcomes for seven patients, alive at the time of the study. Both local radiotherapy and intravitreal chemotherapy achieved good ocular control with acceptable side effects and no significant difference in visual outcome. VRL is a difficult diagnosis and vitreous cytology should be prioritised in cases of vitritis unresponsive to treatment. Analysis of MYD88 L265P mutation and IL- 10: IL- 6 ratio >1 are useful adjuncts in the diagnosis of VR- LBCL, particularly in cases where limited vitreous material makes cytological evaluation challenging.
Assuntos
Neoplasias da Retina , Humanos , Masculino , Feminino , Idoso , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento , Neoplasias da Retina/patologia , Neoplasias da Retina/terapia , Neoplasias da Retina/genética , Idoso de 80 Anos ou mais , Corpo Vítreo/patologia , Linfoma Difuso de Grandes Células B/patologia , Linfoma Difuso de Grandes Células B/terapia , Linfoma Difuso de Grandes Células B/genética , Linfoma Intraocular/patologia , Linfoma Intraocular/terapia , Linfoma Intraocular/genética , Linfoma Intraocular/diagnóstico , Vitrectomia , Neoplasias Oculares/patologia , Neoplasias Oculares/terapia , Neoplasias Oculares/genéticaRESUMO
Chronic B-cell receptor signals incited by cognate antigens are believed to play a crucial role in the pathogenesis of mucosa-associated lymphoid tissue lymphomas. We have explored the immunoglobulin variable regions (IGHV) expressed by 124 ocular adnexal MALT lymphomas (OAML) and tested the in vitro reactivity of recombinant IgM derived from 23 OAMLs. Six of 124 OAMLs (5%) were found to express a high-affinity stereotyped rheumatoid factor. OAMLs have a biased IGHV4-34 usage, which confers intrinsic super auto-antigen reactivity with poly-N-acetyllactosamine (NAL) epitopes, present on cell surface glycoproteins of erythrocytes and B cells. Twenty-one OAMLs (17%) expressed IGHV4-34-encoded B-cell receptors. Five of the 23 recombinant OAML IgMs expressed IGHV4-34, four of which bound to the linear NAL i epitope expressed on B cells but not to the branched NAL I epitope on erythrocytes. One non-IGHV4-34-encoded OAML IgM was also reactive with B cells. Interestingly, three of the 23 OAML IgMs (13%) specifically reacted with proteins of U1-/U-snRNP complexes, which have been implicated as cognate-antigens in various autoimmune diseases such as systemic lupus erythematosus and mixed connective tissue disease. The findings indicate that local autoimmune reactions are instrumental in the pathogenesis of a substantial fraction of OAMLs.
Assuntos
Autoantígenos , Neoplasias Oculares , Imunoglobulina M , Linfoma de Zona Marginal Tipo Células B , Humanos , Linfoma de Zona Marginal Tipo Células B/imunologia , Linfoma de Zona Marginal Tipo Células B/genética , Autoantígenos/imunologia , Imunoglobulina M/imunologia , Imunoglobulina M/metabolismo , Neoplasias Oculares/imunologia , Neoplasias Oculares/genética , Feminino , Pessoa de Meia-Idade , Receptores de Antígenos de Linfócitos B/metabolismo , Receptores de Antígenos de Linfócitos B/imunologia , Receptores de Antígenos de Linfócitos B/genética , Linfócitos B/imunologia , Linfócitos B/metabolismo , Masculino , Idoso , Região Variável de Imunoglobulina/genética , Região Variável de Imunoglobulina/imunologia , Idoso de 80 Anos ou mais , Epitopos/imunologia , Adulto , Fator Reumatoide/imunologiaRESUMO
OBJECTIVE: Apart from the role of the retinoblastoma gene, the genomic events associated with poor outcomes in patients with ophthalmic tumors are poorly understood. METHODS: We retrospectively analyzed 48 patients with six types of ophthalmic tumors. We searched for high-frequency mutated genes and susceptibility genes in these patients using combined exome and transcriptome analysis. RESULTS: We identified four clearly causative genes (TP53, PTCH1, SMO, BAP1). Susceptibility gene analysis identified hotspot genes, including RUNX1, APC, IDH2, and BRCA2, and high-frequency gene analysis identified several genes, including TP53, TTN, and MUC16. Transcriptome analysis identified 5868 differentially expressed genes, of which TOP2A and ZWINT were upregulated in all samples, while CFD, ELANE, HBA1, and HBB were downregulated. Kyoto Encyclopedia of Genes and Genomes enrichment analysis indicated that the phosphoinositide 3-kinase (PI3K)-Akt and Transcriptional misregulation in cancer signaling pathways may be involved in ophthalmic tumorigenesis. CONCLUSIONS: TP53 is clearly involved in ophthalmic tumorigenesis, especially in basal cell carcinoma, and the PI3K-Akt signaling pathway may be an essential pathway involved in ophthalmic tumorigenesis. RUNX1, SMO, TOP2A, and ZWINT are also highly likely to be involved in ophthalmic tumorigenesis, but further functional experiments are needed to verify the mechanisms of these genes in regulating tumorigenesis.
Assuntos
Neoplasias Oculares , Genômica , Mutação , Proteína Supressora de Tumor p53 , Humanos , Feminino , Masculino , Proteína Supressora de Tumor p53/genética , Genômica/métodos , Neoplasias Oculares/genética , Estudos Retrospectivos , Pessoa de Meia-Idade , Regulação Neoplásica da Expressão Gênica , Predisposição Genética para Doença , Receptor Patched-1/genética , Perfilação da Expressão Gênica , Receptor Smoothened/genética , Receptor Smoothened/metabolismo , Proteínas Supressoras de Tumor/genética , Idoso , Proteínas de Ligação a Poli-ADP-Ribose/genética , Adulto , Transdução de Sinais/genética , Fosfatidilinositol 3-Quinases/genética , Fosfatidilinositol 3-Quinases/metabolismo , Biomarcadores Tumorais/genética , Proteínas Proto-Oncogênicas c-akt/genética , Proteínas Proto-Oncogênicas c-akt/metabolismo , DNA Topoisomerases Tipo II , Ubiquitina Tiolesterase , Subunidade alfa 2 de Fator de Ligação ao CoreRESUMO
BACKGROUND: Large genomic databases enable genetic evaluation in terms of haploinsufficiency and prevalence of missense and synonymous variants. We explored these parameters in ocular tumour-associated genes. METHODS: A curated list of ocular tumour-associated genes was assessed using the genomic databases Genome Aggregation Database (gnomAD) and DatabasE of genomiC varIation and Phenotype in Humans using Ensembl Resources (DECIPHER) and compared with breast and lung cancer-associated gene lists. Haploinsufficiency was determined based on specific criteria: probability of loss of function index ≥0.9 in gnomAD, upper CI O/E limit <0.35 for loss of function variants in gnomAD and/or a DECIPHER pHaplo ≥0.86. UniProt was used for further gene characterisation, and gene ontology Protein Analysis THrough Evolutionary Relationships was explored for common biological pathways. In addition, we identified genes with under-representation/over-representation of missense/synonymous variants. RESULTS: Fifty-seven genes were identified in association with ocular and extraocular tumours.Regarding haploinsufficiency, 41% of genes met the criteria for negative selection, with 57% categorised as tumour-suppressing and 39% as oncogenic. Most genes were involved in regulatory processes. Regarding triplosensitivity, 33% of genes reached significance and 83% of these were haploinsufficient. Analysis of variants revealed under-representation of missense variants in 23% of genes and over-representation of synonymous variants in 5% of genes. Ocular tumour-associated genes exhibited higher scores for haploinsufficiency and triplosensitivity compared with breast and lung cancer-associated genes. Pathway analysis revealed significant enrichment in cellular proliferation, differentiation and division. Encoded proteins of ocular tumour-associated genes were generally longer than the median of the UniProt database. CONCLUSION: Our findings highlight the importance of negative selection in ocular tumour genes, supporting cranial gene conservation. This study provides insights into ocular tumourigenesis and future research avenues.
Assuntos
Neoplasias Oculares , Neoplasias Pulmonares , Humanos , Proteínas , Haploinsuficiência/genética , Genômica , Neoplasias Oculares/genéticaRESUMO
Introduction. Retinoblastoma is a childhood cancer of the retina originated by altered or null retinoblastoma protein (pRb) expression. Genetic alterations in both RB1 alleles in the retinal cells are required for the development of retinoblastoma. In the sporadic form, non-hereditary RB1 gene mutations take place in a single retinoblast cell, and are therefore only present in tumor DNA (somatic mutations). Sporadic retinoblastoma is primarily unilateral, lacks family history and has no risk of transmission to descendants. Genetic tests for detection of RB1 mutation has improved the identification of carriers and facilitated accurate genetic counseling. Objective. To identify mutations in the RB1 gene in Colombian patients with sporadic retinoblastoma by PCR-SSCP followed by sequence. Materials and methods. Four patients with sporadic retinoblastoma were analyzed by PCR-SSCP, followed by DNA sequencing to identify variations in the RB1 gene. Results. We identified five variations in RB1 gene: three new mutations (one germline and two somatic mutations), one new polymorphism and one already reported somatic mutation. Four mutations were found in three patients with unilateral retinoblastoma and one mutation was found in a patient with bilateral retinoblastoma. One of these was a germline mutation in a sporadic unilateral retinoblastoma that was not present in the parents or three siblings analyzed. Conclusions. Our results emphasize the importance of identifying mutations for genetic counseling and clinical management of sporadic retinoblastoma patients. Description of a new RB1 gene variant is interesting since there have been a small number of polymorphisms reported for this gene.
Introducción. El retinoblastoma es un cáncer pediátrico de la retina originado por la expresión alterada o ausente de la proteína del retinoblastoma (pRb). Se requiere la alteración genética de ambos alelos RB1 en las células de la retina para el desarrollo del retinoblastoma. En la forma esporádica, las mutaciones no hereditarias del gen RB1 ocurren en un solo retinoblasto y están presentes sólo en el ADN del tumor (mutaciones somáticas). El retinoblastoma esporádico es generalmente unilateral, no tiene historia familiar y no tiene riesgo de transmisión a la descendencia. Las pruebas genéticas para la detección de mutaciones en RB1 han mejorado la identificación de portadores y han facilitado la precisión de la asesoría genética. Objetivo. Detectar mutaciones en el gen RB1 en pacientes colombianos con retinoblastoma esporádico mediante PCR-SSCP seguido de secuenciación. Materiales y métodos. Se analizaron cuatro pacientes con retinoblastoma esporádico para la detección de variaciones en el gen RB1 mediante PCR-SSCP, seguida de secuenciación. Resultados. Se identificaron cinco variaciones del gen RB1 : tres mutaciones nuevas (una de línea germinal y dos somáticas), un polimorfismo nuevo y una mutación somática ya reportada. Las cuatro mutaciones se encontraron en tres pacientes con retinoblastoma unilateral y uno con bilateral. La mutación germinal se detectó en un paciente con compromiso unilateral y no se encontró en los padres ni en los tres hermanos analizados. Conclusión. Estos resultados enfatizan la importancia, para asesoría genética y manejo clínico, de identificar mutaciones del gen RB1 en pacientes con retinoblastoma esporádico. La descripción de una nueva variante en RB1 es interesante, dado el muy bajo número de polimorfismos reportados para este gen.
Assuntos
Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Neoplasias Oculares/genética , Genes do Retinoblastoma , Mutação , Retinoblastoma/genética , Análise Mutacional de DNA , DNA de Neoplasias/análise , DNA de Neoplasias/sangue , DNA de Neoplasias/genética , Neoplasias Oculares/sangue , Mutação da Fase de Leitura , Mutação em Linhagem Germinativa , Neoplasias Primárias Múltiplas/sangue , Neoplasias Primárias Múltiplas/genética , Linhagem , Reação em Cadeia da Polimerase , Polimorfismo Conformacional de Fita Simples , Retinoblastoma/sangue , Análise de Sequência de DNARESUMO
In order to define the molecular and cellular bases of the development of retinoblastomas it is necessary to know its etiology, and to apply the advances in genome technology to this kind of neoplasia. Retinoblastomas are childhood tumors of the eye with an average incidence of one case in every 15,000-20,000 live births, which occur in sporadic and hereditary forms. The sporadic form appears regularly as a unilateral tumor, while in the familial form of the disease, tumors may be unilateral and bilateral. This neoplasia is characterized by leukocoria, strabism, and heterochromia. The retinoblastoma gene (RBl) is a molecular marker of retinoblastoma tumors. This gene is located in chromosome 13q14.2 and encodes a nuclear phosphoprotein (pRB) of 110 KDa, which plays a major role in cell proliferation control through cell cycle-regulated phosphorylation/dephosphorylation cycles of this protein. The RBl gene is mainly affected by point mutations, which occur most frequently in exons 3, 8, 18 and 20. At the end of the last century, DNA technology has improved notably, allowing for its application to the study of a vast array of diseases. The aim of this work is to show the molecular aspects involved in retinoblastoma which are currently deciphering; this is possible thanks to new technology platforms that have been developed. This will allow us in a near future, to offer tests for the early diagnoses, prognoses, and the determination of individual predisposition towards this neoplasia.
El retinoblastoma es una neoplasia embrionaria que se manifiesta en dos formas: esporádica (no heredada) o familiar (heredada). En los casos esporádicos el tumor es unilateral y en la forma familiar puede presentarse de manera unilateral o bilateral. Esta neoplasia tiene una incidencia promedio de 1/15,000 nacidos vivos, presentando signos y síntomas que incluyen leucocoria, estrabismo, midriasis unilateral y heterocromía. El gen que predispone al desarrollo de retinoblastoma es RBl y se localiza en el cromosoma 13 en la región ql4.2. El gen RBl codifica para una fosfoproteína nuclear que participa de manera importante en la regulación del ciclo celular. De acuerdo con la hipótesis de Knudson, para que se desarrolle la neoplasia se deben presentar dos mutaciones en el gen RBl. Las mutaciones puntuales son las que más frecuentemente se presentan en el gen RBl; la mayoría de los estudios indican que los exones 3, 8, 18, 19 y 20 son las regiones de mutación preferencial. En la áltima década ha habido un gran avance en la tecnología del DNA, lo cual hace posible su aplicación en diferentes enfermedades. Estas herramientas moleculares podrían ser de gran utilidad en el diagnóstico o conocimiento de la predisposición a desarrollar un retinoblastoma. Entre estas valiosas herramientas se cuenta con la hibridación fluorescente realizada in situ, hibridación genómica comparativa, las microhileras y por áltimo la identificación de polimorfismos de un sólo nucleótido. En conclusión, actualmente se están descifrando los aspectos moleculares que están relacionados con el retinoblastoma, gracias a la aplicación de nuevas plataformas tecnológicas. Esto permitirá en un futuro próximo ofrecer pruebas para un diagnóstico temprano o para conocer el pronóstico y la predisposición de individuos a desarrollar esta patología. Con el fin de entender las bases celulares y moleculares del desarrollo del retinoblastoma, el objetivo del presente trabajo es mostrar el estado del arte del conocimiento de esta neoplasia, así como su origen y los avances en la genómica aplicada al retinoblastoma.
Assuntos
Humanos , Recém-Nascido , Neoplasias Oculares/genética , Genes do Retinoblastoma , Proteína do Retinoblastoma/fisiologia , Retinoblastoma/genética , Ciclo Celular/fisiologia , Divisão Celular/genética , Divisão Celular/fisiologia , /genética , Metilação de DNA , Éxons/genética , Neoplasias Oculares/diagnóstico , Neoplasias Oculares/epidemiologia , Regulação da Expressão Gênica , Técnicas Genéticas , Incidência , Neoplasias Primárias Múltiplas/genética , Fosforilação , Mutação Puntual , Processamento de Proteína Pós-Traducional , Retinoblastoma/diagnóstico , Retinoblastoma/epidemiologiaRESUMO
Retinoblastoma éum tumor originado de células neuropiteliais da retina, que pode ocorrer de forma esporádica ou familial e está relacionado com o gene RB-1, do braço longo do cromossomo 13 (regiäo 13q14). Este gene é um supressor tumoral e quando sofre deleçäo promove crescimento celular. O retinoblastoma relaciona-se com a mutaçäo dos dois alelos RB-1: quando o indivíduo sofre duas mutaçöes durante o desenvolvimento somático da retina, ele tem a forma esporádica ou näo hereditária da doença; quando uma das mutaçöes é herdada de células germinativas, ele tem a familial ou hereditária. Apresentamos um caso de retinoblastoma bilateral, familial, associado com carcinoma primário de plexo coróide. Após revisäo, näo encontramos associaçäo semelhante na literatura.
Assuntos
Humanos , Lactente , Neoplasias do Plexo Corióideo/diagnóstico , Neoplasias do Plexo Corióideo/cirurgia , Neoplasias Oculares/genética , Retinoblastoma/complicações , Retinoblastoma/genética , Cromossomos Humanos Par 13 , Genes do RetinoblastomaRESUMO
O retinoblastoma é o tumor ocular mais freqüente na infância, geralmente diagnosticado nos primeiros três anos de vida, podendo ser uni ou bilateral. Acredita-se que seja de etiologia gênica e atualmente, com o aumento na sobrevida destes pacientes, tem-se observado outros tumores primários associados, mais freqëntemente o osteossarcoma osteoblástico. Os autores relatam dois casos de osteossarcoma osteoblástico em crianças que foram submetidas anteriormente a enucleaçäo de olho bilateral e unilateral, respectivamente, por retinoblastoma, O objetivo deste trabalho é apresentar dois novos casos na literatura médica e descrever consideraçöes sobre a correlaçäo entre as duas entidades.
Assuntos
Humanos , Feminino , Pré-Escolar , Criança , Neoplasias Oculares/terapia , Neoplasias Ósseas/diagnóstico , Osteossarcoma/diagnóstico , Retinoblastoma/terapia , Segunda Neoplasia Primária/diagnóstico , Neoplasias Oculares/genética , Neoplasias Ósseas/genética , Osteossarcoma/genética , Retinoblastoma/genéticaRESUMO
Inactivation of the Rb (retinoblastoma) tumor suppressor gene is associated with hereditary and sporadic cases of retinoblastoma and other Rb-related tumors. Early diagnosis and genetic counseling heavily depend on practical methods for the detection of Rb deletions and mutations in high-risk families. Here we report on the use of a pair of primers in polymerase chain reaction (PCR) to amplify a 945-bp fragment from intron 17 of the Rb gene (T.L. McGee, G.S. Cowley, D.W. Yandell and T.P. Dryja, 1990, Nucleic Acid Research, 18: 207). Xbal digestion of the PCR product reveals 2 allelic versions: a single 945-bp fragment (allele 1) or 2 fragments of 315 and 630 bp (allele 2). We used total genomic DNA (blood and tumors) to investigate the power of this PCR-Rb-Xbal-RFLP in the identification of both segregation and loss of heterozygosity of the Rb gene. In one family studied (family 1A) in which 2 generations were affected, it was possible to localize the mutated Rb gene to Xbal-Rb allele 2. The assay of loss of heterozygosity of the Rb gene is available for all Xbal-Rb allele 1-2 individuals, so that analyses may be applied in large scale investigation of the participation of Rb gene in tumor development. We conclude that PCR-Rb-Xbal-RFLP is a practical and powerful tool for oncology research and genetic counseling
Assuntos
Humanos , Masculino , Feminino , Neoplasias Oculares/genética , Genes do Retinoblastoma/genética , Polimorfismo de Fragmento de Restrição , Retinoblastoma/genética , Triagem de Portadores Genéticos , Íntrons/genética , Linhagem , Polimorfismo Genético/genética , Reação em Cadeia da Polimerase , Regulação Neoplásica da Expressão Gênica/genéticaRESUMO
Se presentan los árboles genealógicos de 8 propositi afectados por retinoblastoma (Rb): 7 bilaterales (RbB) y uno unilateral (RbU). Se señala que las variaciones intrafamiliares se analizaron teniendo en cuenta que la penetrancia del gen Rb que se ha estimado es del 80 %, el modelo mutacional multietapa propuesto por knudson y la hipótesis resistencia-hospedero de Matsunaga
Assuntos
Recém-Nascido , Lactente , Humanos , Masculino , Feminino , Neoplasias Oculares/genética , Linhagem , Retinoblastoma/genéticaRESUMO
Os autores relatam um caso de retinoblastoma familiar associado ao aparecimento de um segundo tumor primário näo ocular e discutem possíveis teorias genéticas que predisporiam a estas duas neoplasias
Assuntos
Adulto , Humanos , Masculino , Condrossarcoma/secundário , Neoplasias Oculares/genética , Neoplasias Maxilares/secundário , Retinoblastoma/genética , Condrossarcoma/diagnóstico , Condrossarcoma/terapia , Neoplasias Oculares/diagnóstico , Neoplasias Oculares/terapia , Neoplasias Maxilares/diagnóstico , Neoplasias Maxilares/terapia , Retinoblastoma/diagnóstico , Retinoblastoma/terapiaRESUMO
Se estudiaron 51 pacientes afectados de retinoblastoma, de los cuales 30 estaban comprometidos en forma unilateral y los 21 restantes en forma bilateral. De ellos se seleccionaron 5 pedigrees completos de casos hereditarios los que nos sirvieron de base para explicar las dos principales teorías de transmisión genética para esta enfermedad: 1) de Auerbach o Mutación Demorada 2) de Kundson o Multietapas Mutacionales. Completamos con asesoramiento y consejo genético
Assuntos
Humanos , Neoplasias Oculares/genética , Retinoblastoma/genéticaRESUMO
É feito um estudo estatístico relativo à freqüência do retinoblasma nos Serviços de Oftalmologia dependentes da Faculdade de Medicina de Lisboa, e muito especialmente no Instituto de Oftalmologia Dr. Gama Pinto. Analisa-se o perfil ecográfico do retinoblastoma em momentos diferentes do seu desenvolvimento e em tipos clínicos distintos. Dá-se relevo especial nas formas unilaterais, de resto as mais freqüentes, ao estudo clínico e ecográfico do olho adelfo. A variedade dos perfis ecográficos contribui para que seja definida uma classificaçäo clínica dos retinoblastomas. Consideram-se as suas características histológicas e faz-se a sua comparaçäo com os perfis ecográficos obtidos. Faz-se para o retinoblastoma, o adequado estudo genético analisando-se as formas seguramente hereditárias e as formas esporádicas. Avalia-se o cariotipo dos doentes e reconhece-se a possibilidade do cariotipo revelador
Assuntos
Lactente , Pré-Escolar , Humanos , Masculino , Feminino , Neoplasias Oculares/diagnóstico , Retinoblastoma/diagnóstico , Neoplasias Oculares/genética , Retinoblastoma/genética , UltrassonografiaRESUMO
Os autores fazem uma revisäo das Facomatoses, com especial enfoque para a Doença de Von Hippel-Lindau. Dois casos (irmäo e irmä) säo apresentados